{"id":"NCT01576952","sponsor":"Sun Pharmaceutical Industries Limited","briefTitle":"Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects","officialTitle":"A Randomized Double-Masked Study to Compare the Ocular Safety, Tolerability, and Efficacy of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2012-04-13","resultsPosted":"2016-07-13","lastUpdate":"2021-11-19"},"enrollment":268,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ocular Inflammation"],"interventions":[{"type":"DRUG","name":"ISV-303","otherNames":[]},{"type":"OTHER","name":"DuraSite Vehicle","otherNames":[]}],"arms":[{"label":"ISV-303","type":"EXPERIMENTAL"},{"label":"DuraSite Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of topical administration of ISV-303 compared with DuraSite Vehicle.","primaryOutcome":{"measure":"Ocular Inflammation","timeFrame":"15 days","effectByArm":[{"arm":"ISV-303","deltaMin":96,"sd":null},{"arm":"Vehicle","deltaMin":16,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":169},"commonTop":["Eye pain","Ocular hypertension","Headache","Iritis"]}}